MedPath
NMPA Approval

Compound Amantadine Hydrochloride Tablets

国药准字H22025497

September 15, 2022

国药准字H22025497

Drug Information

复方金刚烷胺氨基比林片

恒帝

片剂

复方

化学药品

September 15, 2022

Company Information

Applicant Company

吉林省辽源市龙山区南康街济康路151号

Manufacturing Company

吉林省辽源市济康路151号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方金刚烷胺氨基比林片 - NMPA 批准文号 | MedPath